Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial)
- 1 September 2017
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 120 (6) , 893-897
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
- European Regional Development Fund
This publication has 27 references indexed in Scilit:
- Discontinuation of statin therapy due to muscular side effects: A survey in real lifeNutrition, Metabolism and Cardiovascular Diseases, 2013
- Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatmentLipids in Health and Disease, 2012
- Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinicEuropean Journal of Internal Medicine, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- A systematic review and meta-analysis on the therapeutic equivalence of statinsJournal of Clinical Pharmacy and Therapeutics, 2009
- Berberine decreases PCSK9 expression in HepG2 cellsAtherosclerosis, 2008
- Effects of Rice Policosanol on Serum Lipoproteins, Homocysteine, Fibrinogen and C-Reactive Protein in Hypercholesterolaemic PatientsClinical Drug Investigation, 2005
- Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statinsNature Medicine, 2004
- Policosanol Modulates HMG-CoA Reductase Activity in Cultured FibroblastsArchives of Medical Research, 2001
- Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitorsJournal of Molecular Medicine, 1988